From farm to table: New Anthoney’s bold step towards an antibiotic-free poultry future

ACROSS the world, from the United States and Canada to the Netherlands, Thailand, and even India, poultry producers are moving towards antibiotic-free farming-but not all are going all the way.

- 

While many have reduced antibiotic use, few can claim what New Anthoney's Group in Sri Lanka has achieved, and that is 100% antibiotic-free poultry, from start to finish.

No antibiotics in the feed, no antibiotics on the farm, and no antibiotics in the final product. This isn't just a marketing gimmick-it's a complete rethinking of how chicken is raised, ensuring a healthier, safer choice for consumers.

Why does this matter to you? Because the overuse of antibiotics in farming has a direct impact on human health. When chickens are routinely given antibiotics, resistant bacteria can develop and make their way into your food, your gut, and ultimately, the wider environment. This means when you or your family get sick, common antibiotics may not work as well anymore. By choosing antibiotic-free chicken, you're not just making a better food choice-you're protecting your health and the health of future generations.

But is antibiotic-free chicken just as good? The answer is yes—if not better.

Chickens raised without antibiotics grow naturally, are healthier, and are fed a high-quality diet designed to keep them strong without medication. The result? Cleaner, safer, and more nutritious chicken on your plate, without any hidden risks. Plus, antibiotic-free farming is better for the environment, reducing the spread of antibiotic-resistant bacteria in soil and water, making it a win for both people and the planet.

New Anthoney's Group is leading the way as Sri Lanka's first and only poultry producer to raise chickens completely free of antibiotics. In a world where food safety and health risks are increasing, this bold move sets a new benchmark-not just for Sri Lanka, but for the entire region.

In recent years, Sri Lanka's poultry industry has faced significant challenges due to the escalating issue of antimicrobial resistance (AMR).